These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30810669)

  • 1. Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention.
    Tan Z; Li L; Ma Y; Geng X
    Braz J Cardiovasc Surg; 2019; 34(1):17-21. PubMed ID: 30810669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.
    Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
    Clin Drug Investig; 2015 Dec; 35(12):777-84. PubMed ID: 26387028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin].
    Su JZ; Xue Y; Cai WQ; Huang QY; Chai DJ; Chen GL; Wang FB; Chen XP; Zhang DS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Sep; 39(9):807-11. PubMed ID: 22321227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
    Shacham Y; Leshem-Rubinow E; Steinvil A; Keren G; Roth A; Arbel Y
    Clin Exp Nephrol; 2015 Oct; 19(5):838-43. PubMed ID: 25492251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the effect of different doses of rosuvastatin on ventricular remodeling in patients with acute coronary syndrome after emergency percutaneous coronary intervention.
    Guo J; Zhang WZ; Zhao Q; Wo JS; Cai SL
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4457-4463. PubMed ID: 29077146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C associates with the prediction of in-stent restenosis among patients receiving stent implantation: results of the 1-year follow-up.
    Zhao C; Yang L; Mao L; Zhong L; Li X; Wei S
    Coron Artery Dis; 2013 Aug; 24(5):357-60. PubMed ID: 23835667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of probucol on preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention].
    Suo XQ; Yang SC; Ma ZH; Sun TT; Zhang WY; Cong HL; Lin WH; Lu CZ; Tian FS; Fu NK
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(41):3234-3238. PubMed ID: 29141361
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention.
    Pang Z; Zhao W; Yao Z
    Med Sci Monit; 2017 Jun; 23():2924-2930. PubMed ID: 28617765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
    Celik T; Iyisoy A; Kursaklioglu H; Turhan H; Kilic S; Kose S; Amasyali B; Isik E
    Coron Artery Dis; 2005 Aug; 16(5):293-9. PubMed ID: 16000887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
    Du Y; Zhao Y; Zhu Y; Hu C; Zhang J; Ji Q; Liu W; Han H; Yang L; Zhang D; Tong S; Wang Z; Guo Y; Liu X; Zhou Y
    J Atheroscler Thromb; 2019 Oct; 26(10):868-878. PubMed ID: 30773518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of three dimensional-speckle tracking imaging for predicting left ventricular function after non-ST-segment elevation myocardial infarction with percutaneous coronary intervention.
    Luo Y; Liu Y; Guan X; Zhang Y; Li J
    J Xray Sci Technol; 2018; 26(2):331-339. PubMed ID: 29562571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.
    Liu HL; Yang Y; Yang SL; Luo JP; Li H; Jing LM; Shen ZQ
    Clin Ther; 2013 Mar; 35(3):261-72. PubMed ID: 23410871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Dapagliflozin in Combination with Metoprolol Sustained-Release Tablets on Prognosis and Cardiac Function in Patients with Acute Myocardial Infarction after PCI.
    Zhang H; Liu Z
    Comput Math Methods Med; 2022; 2022():5734876. PubMed ID: 35966250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of probucol combined with hydration in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention: a multicenter, prospective, randomized controlled study.
    Fu N; Yang S; Zhang J; Zhang P; Liang M; Cong H; Lin W; Tian F; Lu C
    Int Urol Nephrol; 2018 Jan; 50(1):105-112. PubMed ID: 29071556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Effects of Ticagrelor and Clopidogrel on Inflammatory Factors, Vascular Endothelium Functions and Short-Term Prognosis in Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention: a Pilot Study.
    Gao CZ; Ma QQ; Wu J; Liu R; Wang F; Bai J; Yang XJ; Fu Q; Wei P
    Cell Physiol Biochem; 2018; 48(1):385-396. PubMed ID: 30016801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive Statin Therapy in NSTE-ACS Patients Undergoing PCI: Clinical and Biochemical Effects.
    Shehata M; Fayez G; Nassar A
    Tex Heart Inst J; 2015 Dec; 42(6):528-36. PubMed ID: 26664304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].
    Cağli KE; Topaloğlu S; Aras D; Günel EN; Ozlü MF; Uygur B; Baysal E; Sen N
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):19-25. PubMed ID: 19225249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity C-reactive protein and long term reperfusion success of primary percutaneous intervention in ST-elevation myocardial infarction.
    Groot HE; Karper JC; Lipsic E; van Veldhuisen DJ; van der Horst ICC; van der Harst P
    Int J Cardiol; 2017 Dec; 248():51-56. PubMed ID: 28826799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.